Search
forResearch 10 of 1000+
- Alopecia Areata and Alopecia Areata Incognita
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- The potential of regulatory T cell-based therapies for alopecia areata
- CUTANEOUS T-CELL LYMPHOMA
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Alopecia Areata
- Immunomodulators in the treatment of cutaneous lymphoma
Learn 1
Community
— no results
Try a deeper search in community →